观察表皮生长因子治疗糖尿病足坏疽皮肤生长的临床疗效  

The clinical efficacy of diabetic foot skin growth observed EGF treatment

作　　者：王桂玲 

机构地区：[1]虎林市红十字医院皮肤科,黑龙江虎林158400

出　　处：《糖尿病新世界》2015年第24期130-132,共3页Diabetes New World Magazine

摘　　要：目的探究表皮生长因子治疗糖尿病足坏疽皮肤生长的临床效果。方法选取2014年1月—2015年6月100例糖尿病足坏疽患者,随机将这100例患者分为实验组(50例)和对照组,实验组给予表皮生长因子治疗,对照组给予山莨菪碱治疗,对比2组糖尿病足坏疽患者治疗的效果。结果实验组糖尿病足坏疽患者皮肤开始生长时间、创面愈合效果与对照组相比,差异具有统计学意义(P<0.05)。结论表皮生长因子可以促进皮肤的生长,在糖尿病足坏疽中的治疗效果较好,可以有效提高患者创面愈合的效果,值得推广应用。Objective Purpose To explore the epidermal growth factor treatment of diabetic foot gangrene skin growth clinical results. Methods January 2014- June 2015 100 cases of diabetic gangrene patients, these 100 patients were randomly divided into experimental group（50 cases） and the control group, the experimental group received the epidermal growth factor treatment, the control group was given anisodamine treatment, compared to patients treated with the effect of gangrene 2diabetes group. Results of skin test group patients with diabetic foot gangrene began to grow time, wound healing effect compared with the control group, there are significant differences（P 〈0.05）. Conclusion EGF can promote the growth of skin, treatment of diabetic foot gangrene better, can effectively improve the patient wound healing effect, it should be widely applied.

关 键 词：表皮生长因子 糖尿病足坏疽 皮肤生长 山莨胆碱 

分 类 号：R587[医药卫生—内分泌]